The ideas and opinions presented in these webinars represent those of the presenters
only and not necessarily those of HESI, or its member organizations

Causal Reasoning in Epidemiology: Philosophy and Logic

by Dr. George Maldonado of the University of Minnesota.

Evidence integration in epidemiology and risk assessment Paolo Boffetta, MD, MPH

by Dr. Boffetta, a Professor in the Department of Family, Population & Preventive Medicine at Stony Brook University and Associate Director for Population Sciences at Stony Brook Cancer Center.

Transparency and Data Sharing in Epidemiology

by Dr. Tim Lash (Rollins School of Public Health, Emory University) and Dr. Brian Nosek (Center for Open Science)

Current Efforts by API, CLI, and HESI to Increase the Impact of Epidemiology in Risk Assessment

Omobola Mudasiru (American Petroleum Institute), Dana Sargent (CropLife International), and Sandrine Deglin (HESI)


A matrix for bridging the epidemiology and risk assessment gap

Burns, C. J., LaKind, J. S., Mattison, D. R., Alcala, C. S., Branch, F., Castillo, J., . . . Zidek, A. (2019).
Global Epidemiology, 1, 100005. doi

Bridging the epidemiology risk assessment gap: An NO2 case study of the Matrix.

LaKind, J. S., Burns, C. J., Erickson, H., Graham, S. E., Jenkins, S., & Johnson, G. T. (2020).
Global Epidemiology, 2, 100017. Doi

Using the Matrix to bridge the epidemiology/risk assessment gap: a case study of 2,4-D.

Burns, C. J., & LaKind, J. S. (2021).
Crit Rev Toxicol, 1-9. doi:10.1080/10408444.2021.1997911

Epidemiology and risk assessment.

Samet JM, Schnatter R, Gibb H.
Am J Epidemiol. 1998 Nov 15;148(10):929-36. doi:
10.1093/oxfordjournals.aje.a009569. PMID: 9829864